Literature DB >> 24461589

The role of central nervous system on hypoglycemia and the feasibility of the brain theory in traditional Chinese medicine on treatment of diabetes mellitus.

Hai-li Jiang1, Jing-jing Niu1, Wei-fei Zhang2, Wen-jin Huang2, Ming-yue Zhou2, Wen-jun Sha2, Jun-yan Li2, Fu-feng Li3, Ting Zhu4, Xin Xia5, Jun Zhang6, Yuan-dong Shen2, Li-gang Zhou7.   

Abstract

The central nervous system (CNS) plays a key regulatory role in glucose homeostasis. In particular, the brain is important in initiating and coordinating protective counterregulatory responses when blood glucose levels fall. This may due to the metabolic dependency of the CNS on glucose, and protection of food supply to the brain. In healthy subjects, blood glucose is normally maintained within a relatively narrow range. Hypoglycemia in diabetic patients can increase the risk of complications, such as heart disease and diabetic peripheral neuropathy. The clinical research finds that the use of traditional Chinese medicine (TCM) has a positive effect on the treatment of hypoglycemia. Here the authors reviewed the current understanding of sensing and counterregulatory responses to hypoglycemia, and discuss combining traditional Chinese and Western medicine and the theory of iatrogenic hypoglycemia in diabetes treatment. Furthermore, the authors clarify the feasibility of treating hypoglycemia on the basis of TCM theory and CNS and have an insight on its clinical practice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24461589     DOI: 10.1016/S2095-4964(14)60008-X

Source DB:  PubMed          Journal:  J Integr Med


  2 in total

1.  A metabolomics approach to stratify patients diagnosed with diabetes mellitus into excess or deficiency syndromes.

Authors:  Tao Wu; Ming Yang; Tao Liu; Lili Yang; Guang Ji
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-18       Impact factor: 2.629

2.  Effects of the Tangningtongluo formula as an alternative strategy for diabetics via upregulation of insulin receptor substrate-1.

Authors:  Long Cheng; Junmei Song; Geng Li; Yue Liu; Yuming Wang; Xiangbao Meng; Guibo Sun; Xiaobo Sun
Journal:  Mol Med Rep       Date:  2017-06-01       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.